Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

754 Press Releases
DateTitleCompany
16 Jul 13 Merck Statement on FDA Advisory Committee Meeting About Sugammadex Sodium Injection Merck,
Published by
Business Wire
01 Jul 13 Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia Merck,
Published by
Business Wire
28 Jun 13 Merck to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30 Merck,
Published by
Business Wire
03 Jun 13 Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013 Merck,
Published by
Pharmiweb.com
30 May 13 Merck to Present at the Sanford C. Bernstein Strategic Decisions Conference Merck,
Published by
Business Wire
28 May 13 Merck Announces Third-Quarter 2013 Dividend Merck,
Published by
Business Wire
24 May 13 Merck Prices $ 6.5 Billion Debt Offering Merck & Co. Inc.,
Published by
Business Wire
24 May 13 Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet Merck,
Published by
Business Wire
24 May 13 Merck Announces $5 Billion Accelerated Share Repurchase Merck,
Published by
Business Wire
24 May 13 Merck Statement on FDA Advisory Committee Meeting for Suvorexant Merck,
Published by
Business Wire
24 May 13 Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine Merck,
Published by
Business Wire
24 May 13 Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference Merck,
Published by
Business Wire
24 May 13 Merck to Present at the UBS Global Healthcare Conference Merck,
Published by
Business Wire
01 May 13 Merck Announces New $15 Billion Share Repurchase Program Merck,
Published by
Business Wire
30 Apr 13 Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims Merck,
Published by
Business Wire
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
24 Apr 13 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck
22 Apr 13 Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C Merck,
Published by
Business Wire
11 Mar 13 Results from HPS2-THRIVE Study of TREDAPTIVE™ (extended-release niacin/laropiprant) Presented at American College of Cardiology Scientific Sessions Merck
12 Mar 13 Merck Provides Update on IMPROVE-IT Trial Merck,
Published by
Business Wire
09 Mar 13 Results from HPS2-THRIVE Study of TREDAPTIVE™ (extended-release niacin/laropiprant) Presented at American College of Cardiology Scientific Sessions Merck,
Published by
Business Wire
01 Apr 13 Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1 Merck,
Published by
Business Wire
12 Apr 13 Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole) Merck
26 Feb 13 Merck to Present at the Citi 2013 Global Healthcare Conference Merck,
Published by
Business Wire
05 Mar 13 Merck to Present at the 33rd Annual Cowen Health Care Conference Merck,
Published by
Business Wire
13 Feb 13 Merck Statement on Venezuelan Currency Devaluation Merck,
Published by
Business Wire
27 Mar 13 Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet Merck,
Published by
Business Wire
20 Feb 13 Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement Merck,
Published by
Business Wire
22 Feb 13 Merck to Present New Data Analyses of its Investigational Ragweed Pollen and Grass Pollen Allergy Immunotherapy Tablets Merck,
Published by
Business Wire
14 Feb 13 Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.